Nitrofurantoin Capsules — Class III drug recall D-0262-2019
Terminated recall by Sandoz Inc, reported 2018-11-21, distributed nationwide. Cross Contamination with Other Products
| Recall number | D-0262-2019 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Sandoz Inc, Princeton, NJ, United States |
| Recall initiated | 2018-11-02 |
| Classified | 2018-11-20 |
| Reported by FDA | 2018-11-21 |
| Terminated | 2020-10-02 |
| Distributed | Nationwide (US) |
| Quantity | 23,053 bottles |
| NDC | 16714-0439-01 |
| Lot numbers | 7320, JA7319, JA7321 |
| Expiration dates | 2020-03 |
Product
Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, 100-count bottoles, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141 Manufactured by: Sandoz Inc. Princeton, NJ 08540,NDC 16714-439-01
Reason for recall
Cross Contamination with Other Products
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0262-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.